• show all 0 hide
You are viewing the full content

Sulfonylureas are oral hypoglycemic drugs widely used in treatment of type2 diabetes. The first generation of sulfonylureas includes tolbutamide, acetohexamide, and chlorpropamide. The second includes glibenclamide, gliclazide, and glimepiride, which are considerably more potent than the earlier agents.

ATP‐dependent K+ Channels

Antidiabetic Drugs Other than Insulin